低TYROBP表达预测多发性骨髓瘤的预后不佳
Hong Luo1,2, Chengyun Pan1, Li Wang1,2
1Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
Cancer cell international
|March 29, 2024
概括
提洛巴是多发性骨髓瘤 (MM) 的潜在预后标志物,是一种耐火性血液癌症. 对TYROBP的下调表明预后不佳,并通过细胞粘附通路影响MM的发展.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多发性髓瘤 (MM) 是一种显著的耐火性血液癌症.
- 识别新的预后标志物对于MM管理至关重要.
研究的目的:
- 为了确定多发性骨髓瘤 (MM) 的新预后标志物.
- 调查TYROBP在MM发展和进展中的作用.
主要方法:
- 差异基因表达分析和权重基因同表达网络分析 (WGCNA) 用于识别MM相关基因.
- 蛋白与蛋白相互作用 (PPI) 分析确定了枢纽基因,包括TYROBP.
- 基因本体学 (GO),基因和基因组的京都百科全书 (KEGG) 和基因组丰富分析 (GSEA) 进行了功能和通路分析.
- 西部涂抹,RT-PCR,细胞粘附和穿孔测试验证了TYROBP的作用.
主要成果:
- 确定了92个差异表达基因 (DEG) 和10个枢纽基因.
- 对TYROBP的下调与令人丧的MM预后相关.
- TYROBP独立预测了MM的预后,并且与细胞粘附途径有关.
- 在MM患者中,TYROBP表达减少,其上调增加了MM细胞粘附和减少迁移.
结论:
- 甲状腺瘤是多发性骨髓瘤 (MM) 的潜在预后标志物.
- TYROBP在MM细胞粘附和迁移中发挥作用,影响疾病的进展.
相关概念视频
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


